Scilex (NASDAQ:SCLX) focuses on developing and bringing to market non-opioid pain management solutions aimed at substantially improving the quality of life for those suffering from pain. With a keen emphasis on innovation and patient safety, Scilex is committed to redefining pain management through its pipeline of products and projects. The company's approach centers on leveraging cutting-edge science and technology to create therapies that can address the needs of the millions of people worldwide who seek effective pain relief without the risk of opioid addiction. Scilex's objectives are firmly rooted in the advancement of novel, safer treatment alternatives that promise both efficacy and accessibility for patients in need.